Overall view of the COVID-19 virus. Note the spikes blue that adorn the outer surface,red, which impart a corona like appearance. (Fusion Animation).
A novel coronavirus was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19). The illustration (left) shows the overall structure of the COVID-19 virus. Note the spikes that adorn the outer surface, colored red, which impart the look of a corona surrounding the virus. A close up view of these spikes can be seen on the right, from studies by McLellan lab[1]. An animation (by Elara Systems) shows how COVID-19 interacts with its host, via these spikes, thus permitting its genome to enter the host (human) cell[1].
Photo credit (to the left): Alissa Eckert, MS; Dan Higgins, MAMS
Potential treatments and ways to minimize exposure to COVID-19
Nature's Vacuum Cleaner - Binding of ACh to AChE
Movie by Richard Gillilan, Israel Silman & Joel L. Sussman
Html5mediator: file extension not recognized
<html>
This is HTML.
</html>
Html5mediator: file extension not recognized
A USA, French UK study identified 69 drugs to test against the coronavirus[2]. As reported in the New York Times (23-Mar-2020) "The researchers sought drugs that also latch onto the human proteins that the coronavirus seems to need to enter and replicate in human cells."
A French study[3] showed, despite its small sample size (20 patients treated), that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.
A summary of key findings about COVID-19 can be found at CDC.
A computer game, Folding@home, developed at the Inst for Protein Design (U Washington), uses crowdsourcing to try to find new lead compound that might become drugs to treat COVID-19.
Crowdfight COVID-19 - A scientific crowdsourcing initiative to put all available resources at the service of the fight against COVID-19
Recent published papers
3D Structure of RNA-dependent RNA polymerase from COVID-19, a major antiviral drug target from the Rao lab in Beijing[4].
Crystal structure of the Mpro from COVID-19 and discovery of inhibitors in a study by scientists from Shanghai & Beijing [5].
Coronavirus Evolved Naturally, and ‘Is Not a Laboratory Construct,’ in a study in Nature Med by Anderson and colleagues [6].
A study by Zhou & colleagues in Science on the structural basis for the recognition of the SARS-CoV-2 (COVID-19) by full-length human ACE2 gives insights to the molecular basis for coronavirus recognition and infection[7].
The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. A study by McLellan and colleagues in "Science" on the Cryo-EM structure of the COVID-19 spike protein. This structure should greatly aid in the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis[1].
Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of COVID-19 in China, with some promising results summarized.[8].
↑ 1.01.11.2Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Feb 19. pii: science.abb2507. doi: 10.1126/science.abb2507. PMID:32075877 doi:https://dx.doi.org/10.1126/science.abb2507
↑ Gordon, et al. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing: bioRxiv (online) 2020 https://doi.org/10.1101/2020.03.22.002386
↑ Gautret, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non-randomized clinical trial: Intl J Antimcrob Agents (in press) 2020 https://dx.doi.org/10.1016/j.ijantimicag.2020.105949
↑Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 4. pii: science.abb2762. doi: 10.1126/science.abb2762. PMID:32132184 doi:https://dx.doi.org/10.1126/science.abb2762
↑Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012. PMID:32147628 doi:https://dx.doi.org/10.5582/ddt.2020.01012